London stocks slide as markets stay wary of global rate outlook

Published 01/13/2025, 05:45 AM
Updated 01/13/2025, 05:46 AM
© Reuters. FILE PHOTO: A man walks through the lobby of the London Stock Exchange in London, Britain, May 14, 2024. REUTERS/Hannah McKay/File Photo
UK100
-
FTMC
-
GB10YT=RR
-
GB30YT=RR
-

(Reuters) - British equities slipped on Monday, caught up in a global selloff as investors shied away from risky assets following a U.S. jobs report last week reinforced bets that the Federal Reserve would be cautious about cutting interest rates this year.

The blue-chip FTSE 100 shed 0.4% as of 1023 GMT, while the domestically-focussed FTSE 250 midcap index lost 0.3%.

Most subsectors traded lower, with aerospace and defence the worst hit, down 1.8%.

Global stocks fell, while bond yields remained elevated after data on Friday showed U.S. job growth unexpectedly accelerated in December while the unemployment rate fell to 4.1%.

The yield on the 30-year gilt jumped to a fresh 27-year high, while the yield on the 10-year note stood at its highest since 2008, extending the selloff into a second week.

British midcaps suffered a near 3% drop last week, hurt by a sharp rise in British borrowing costs that fuelled concerns about public finances following big spending plans announced by the government.

Energy was an outlier, up 1.2% as crude oil prices gained on wider U.S. sanctions on Russian oil and the expected effects on exports to top buyers India and China. [O/R]

The elevated crude oil prices weighed on airline stocks, with the travel and leisure sector down 1.3%.

Later this week, inflation figures will be in focus in the UK, along with most of Europe and the United States. UK quarterly GDP estimates will also be released on Thursday.

Among headlining stocks, Entain rose 1.4% after the gambling group said it expects 2024 core profit to be at the top end of its forecast range.

© Reuters. FILE PHOTO: A man walks through the lobby of the London Stock Exchange in London, Britain, May 14, 2024. REUTERS/Hannah McKay/File Photo

Biotech firm Oxford Nanopore Technologies jumped 14.4% after forecasting full -year revenue of about 183 million pounds ($222.27 million) vs. 169.7 million a year prior.

PageGroup dipped 3.9% after the recruiter issued its second profit warning in six months.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.